Los Gatos, Calif., January 30, 2026 – MedTech Outlook has recognized Orlucent with the 2026 Handheld Fluorescent Molecular Imaging System of the Year Award. MedTech Outlook is a resource for leaders and innovators navigating the rapid, technology-driven transformation in healthcare. In an article describing their selection for the award, the magazine highlighted the biological insight provided by the Orlucent® Skin Fluorescent Imaging System and the benefits to patients, physicians and the healthcare system. Orlucent’s technology identifies biological changes in suspicious moles, equipping physicians with an objective measure for determining a plan of care at the time of the patient visit. As the article headline states, Orlucent is “a new standard for mole evaluation”.